Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice

Research output: Contribution to journalJournal articleResearchpeer-review

Kirsten R Jacobsen, Natasha Fauerby, Zindy Raida, Otto Kalliokoski, Jann Hau, Flemming F Johansen, Klas SP Abelson

Laboratory mice constitute an extensively used model to study the pathologic and functional outcomes of cerebral ischemic stroke. The middle cerebral artery occlusion (MCAO) model requires surgical intervention, which potentially can result in postsurgical pain and stress. In the present study, we investigated whether buprenorphine and meloxicam, at clinically relevant doses provided pain relief without altering infarct volume in male C57BL/6 mice. Common known side-effects of buprenorphine, including decreased food consumption, were noted after surgery in buprenorphine-treated mice, but these effects were brief and seen only during the treatment period. Fecal corticosterone metabolites did not differ significantly between the groups. In the present study, buprenorphine treatment did not alter infarction volume when compared with that of mice that did not receive analgesia. In contrast, meloxicam treatment significantly reduced infarct volume and may be a confounder if used as an analgesic during MCAO surgery. Furthermore, investigation of behavioral profiles by using an automated behavioral scoring system showed that rearing and sniffing behaviors decreased as infarct volume increased. This suggests that studies of exploratory behavior may aid in developing new markers of short-term stroke-related behavioral deficiencies in laboratory mice.
Original languageEnglish
JournalComparative Medicine
Volume63
Issue number2
Pages (from-to)105-13
Number of pages9
ISSN1532-0820
Publication statusPublished - Apr 2013

ID: 46436107